American Society for Experimental Neurotherapeutics (ASENT) 2025 Annual Meeting

American Society for Experimental Neurotherapeutics (ASENT) 2025 Annual Meeting is organized by American Society for Experimental Neurotherapeutics (ASENT) and will be held from Mar 12 - 14, 2025 at Hyatt Regency Bethesda, Bethesda, Maryland, United States of America.

Description:
ASENT's 2025 Annual Meeting is the premier neuroscience and neurotherapeutics conference where senior leaders from healthcare payers, providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders and innovation centers gather to improve the process of bringing neurotherapeutics to market.

The Meeting features 12 symposia, which address therapeutic advances in a broad range neurologic disease states, processes and delivery methods; as well as interactive poster presentations, ASENT's celebrated pipeline presentations, and live discussion with speakers at the end of each day.

The plenary sessions, panel discussions, outstanding pipeline presentations and poster sessions focus on the latest science in neurotherapeutics. The conference content will focus on the latest science in neurotherapeutics including innovations across disease states, novel delivery systems, gene therapy and biomarkers, and of course the latest drug therapies and devices. The event features plenary sessions, panel discussions, satellite luncheons, networking meetings, pipeline presentations and poster sessions.

2025 Meeting Highlights:

• 12 - 16 Scientific Symposia featuring Neuroscience leaders from Industry, Academia, FDA, NIH, and Advocacy
• DEBATE: Featuring a hot topic and current data
• CNS PIPELINE Presentations
• CAREER DINNER Featuring Guest Speakers
• Interactive Poster Discussions
• Sponsored Symposia from Innovation Leaders
• Live Discussions in Breakout Rooms with Speakers
• 2nd Annual Neurotherapeutics Clinical Trial Course - LIVE  (application only)

This year our program will include symposia on:

• Gene targeted therapy for Epilepsy
• Universal Framework for Staging of Neurodegenerative Diseases
• A Broader Look at Patient Focused Drug Development
• Immunotherapy of Neurodegenerative Disorders
• An Update on Pediatric Neurotherapeutics
• Novel Therapies in Duchenne and Becker’s Muscular Dystrophy
• Global Neuroinfectious Disease
• Autoimmune Therapeutics presented in conjunction with the Japanese Society of Neurological Therapeutics
• Diversity and Equity in Clinical Trials
• ”Tell me about it” speech analysis in Neurodegenerative Diseases
• Update on Pain Therapeutic Opportunities
• Updates in Neurovascular and Stroke Therapeutics
• Interactive Poster Discussions
• Dynamic Pipeline Presentations
• Live Discussions in Breakout Rooms with Speakers
• And much, much more!